Q5168 Medicaid Rate by State

Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg

11 state Medicaid programs publish a fee-for-service rate for Q5168 (injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg), ranging from $25.67 in Illinois to $26.38 in Kansas among rates on the same basis.

Every state, kept current

Any code, across the states that list it: the Rates plan

$29 /mo, 7-day free trial

  • The full schedule for each of 50 states and DC
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial$29/mo after the trial; a trial exports 50-row samples

Or one file, no account: State-Specific Services across 46 states, 1,476 codes.

2026-11-22 edition, standardized by ProviderSignal. Secure checkout by Stripe; download link by email, 5 downloads in 30 days. License · Every file we sell

Publishing states

11

Median % of Medicare

--

Rate range, like rates

$25.67 - $26.38

Q5168 rates in every publishing state

  • Arkansas$307.04

    Far above other states: the unit may differ.

    2026

  • Arizona$21.11

    hospital outpatient payment

    2026

  • Illinois$25.67

    2026

  • Kansas$26.38

    2026

  • Michigan$26.38

    2026

  • Minnesota$26.38

    Prior auth: required, 2026

  • Montana$26.38

    surgery center payment

    2026

  • Nebraska$26.38

    2026

  • Oklahoma$26.38

    2026

  • Utah$26.38

    Prior auth: not required, 2026

  • Wisconsin$975.00

    Far above other states: the unit may differ.

    2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. A state that lists the code more than one way shows one of its rows here, with its basis: a rental is not a purchase price. "--" in the prior-auth column means the state publishes no PA flag.

Related state-specific services codes

All 58 codes from Q5098 to Q5169 or every state-specific services code by number.

Frequently asked questions

How much does Medicaid pay for Q5168?

11 state Medicaid programs publish a fee-for-service rate for Q5168 (injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg), ranging from $25.67 in Illinois to $26.38 in Kansas among rates on the same basis. The full table on this page lists every publishing state's current rate.

Which state pays the most for Q5168?

Kansas publishes the highest Medicaid rate for Q5168 at $26.38. Illinois publishes the lowest at $25.67, among rates on the same basis; rentals and rates far from the other states' are in the table with their basis.

Does Q5168 require prior authorization under Medicaid?

1 of the 11 publishing states flag Q5168 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".